HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Effort To Harmonize Cosmetics Regs Should Include Public Input – Sen. Kerry

This article was originally published in The Rose Sheet

Executive Summary

FDA should take steps to ensure that the public can participate in an initiative to bring international cosmetics regulations closer to alignment, Senator John Kerry (D-Mass.) stated in a Sept. 26 letter to FDA Commissioner Andrew von Eschenbach

You may also be interested in...



FDA preps for upcoming ICCR

Public meeting will be held June 19 in Rockville, Md. to provide information and receive comments related to International Cooperation on Cosmetics Regulations (ICCR), a voluntary effort between U.S., Japan, the EU and Canada to remove regulatory obstacles to international trade. FDA will go over topics to be discussed at second round of ICCR steering committee and expert working group meetings in Washington, D.C. the week of July 28, according to the agency's recent notice. In fall 2007, Senator John Kerry, D-Mass., lamented the public's exclusion from the first ICCR meeting in a letter to FDA Commissioner Andrew von Eschenbach (1"The Rose Sheet" Oct. 1, 2007, p. 3). An FDA document detailing the outcome of ICCR's first round of talks became available in March; FDA is accepting comments through July 2 (2"The Rose Sheet" March 10, 2008, In Brief)...

FDA preps for upcoming ICCR

Public meeting will be held June 19 in Rockville, Md. to provide information and receive comments related to International Cooperation on Cosmetics Regulations (ICCR), a voluntary effort between U.S., Japan, the EU and Canada to remove regulatory obstacles to international trade. FDA will go over topics to be discussed at second round of ICCR steering committee and expert working group meetings in Washington, D.C. the week of July 28, according to the agency's recent notice. In fall 2007, Senator John Kerry, D-Mass., lamented the public's exclusion from the first ICCR meeting in a letter to FDA Commissioner Andrew von Eschenbach (1"The Rose Sheet" Oct. 1, 2007, p. 3). An FDA document detailing the outcome of ICCR's first round of talks became available in March; FDA is accepting comments through July 2 (2"The Rose Sheet" March 10, 2008, In Brief)...

Senators Request FDA Inquiry Into Lead Discovered In Lipstick Products

FDA should "take immediate action" to reduce consumer exposure to lead in lipstick and other cosmetic products, a trio of U.S. Senators assert in a Nov. 19 letter to FDA Commissioner Andrew von Eschenbach, M.D

Related Content

UsernamePublicRestriction

Register

RS014990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel